In-Silico Study of Novel Folate Analogues as Anticancer which Inhibits Dihydrofolate Reductase

Didy Yoga Lucky Prayoga, Romdani Achmad Septiawan, Erwin Jingga, Prima Alifian Hergaputra, Erwin Chandra Christiawan, Rebhika Lusiana, Rendha Kusumaning Kristiwi, Siswandono Siswandono

Abstract


Dihydrofolate reductase (DHFR) has an important function in folic analogues biosynthesis which is used as nutrition for cells. In a specific cancer cell, DHFR has bigger expression than normal cells therefore it is good candidates as target to cancer chemotherap. In this research the screening have been done to 10-N-(4’-bromobenzoyl) folic acid and 10-N-(p-toluoyl) folic acid by in silico method. The result of molecular docking shows that those two compounds have more stable interaction than other DHFR inhibitors (methotrexate) but those two compound do not follow the Lipinsky’s rule of 5 which is affected to its bioavailability.

Keywords


Cancer; DHFR; In-silico; Folate analogues

Full Text:

PDF

References


D. Brundage, Oncologic Disorders at: J. T. DiPiro, et al. eds. Pharmacotherapy Principles dan Practice. New York: The McGraw-Hill Companies, Inc., 2008, p.1277.

F. Bray, J.S. Ren, E. Masuyer, J. Ferlay, International Journal of Cancer, 132 (2013) 5.

A. Gangjee, H.D. Jain, R.L. Kisliuk, Bioorganic and Medicinal Chemistry Letters, 15 (2005).

S.C. Sweetman, Antineoplastic. In: S.C. Sweetman, ed. Martindale the Complete Drug Reference. 36th Edition ed. London: Pharmaceutical Press, 2009.

T.I. Oprea, A.M. Davis, S.J. Teague, P.D. Leeson, J Chem Inf Comput Sci 41 (2001) 5.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

e-ISSN No: 2356-2536
p-ISSN No: 2528-6854

Supported by :


Jurnal Online
Management Jurnal Elektronik


Pusat Dokumentasi dan Informasi Ilmiah
Lembaga Ilmu Pengetahuan Indonesia



Indexed by :